Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented ...

Co-Diagnostics, Inc. (NASDAQ:CODX) announced on Monday that it has entered into a joint venture agreement with the Kingdom of ...

Antimicrobial resistance (AMR) represents one of the most pressing global health challenges of the 21st century, threatening the effectiveness of treatments and burdening healthcare systems worldwide.

Insight Molecular Diagnostics Inc. (($IMDX)) announced an update on their ongoing clinical study. Study Overview: The GraftAssureDx Study, ...

Investing.com -- Co-Diagnostics Inc (NASDAQ:CODX) stock plunged 54.8% Tuesday after the molecular diagnostics company announced a registered direct offering that will significantly dilute existing ...

In the following sections, we highlight ethical concerns about early adoption of molecular diagnostic testing without solid evidence or guidelines and offer practical guidance for ethical ...

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key ...

TORINO, Italy--(BUSINESS WIRE)-- Bruker Corporation (Nasdaq: BRKR) is pleased to announce the closing of its acquisition of ELITechGroup (“ELITech”) for €870 million in cash, excluding the carved out ...

Our Bureau, Bengaluru Monday, October 27, 2025, 16:15 Hrs [IST] ...

Understanding molecular diversity is fundamental to biomedical research and diagnostics, but existing analytical tools ...

Globally, synovial sarcoma remains a rare but aggressive malignancy with a 5-year survival rate of 70% to 80% and a 10-year ...